Awardee OrganizationUNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Description
Abstract Text
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The spliceosome is the cellular machine responsible for removing the introns that interrupt nearly all human gene transcripts. In a highly dynamic series of molecular interactions, the spliceosome is assembled on each intron from on the order of 150 proteins, as well as 5 structural RNAs. The Jurica group has developed a protocol isolate to spliceosomes assembled in vitro on a synthetic splicing substrate from HeLa cell nuclear extract. LC-MS/MS analysis of these complexes identified a potential "parts list" of over 200 proteins, although the stoichiometric presence of many of these proteins remains to be verified. Control experiments indicate that a subset of the proteins bind the pre-mRNA even in the absence of splicing. In order to further define the composition of the core spliceosome complex Jurica will use mass spectrometry to identify proteins associated with the spliceosome when flanking pre-mRNA is released. They will also compare the composition of C complex assembled on other pre-mRNA splicing substrates and employ isotope tagging to allow more quantitative comparison of these different samples. Additionally, they will identify proteins that are exposed on the surface of the spliceosome by chemically modifying purified spliceosome complexes under both native and denaturing conditions. Using mass spectrometry to analyze peptides derived from these samples, they can conclude that peptides modified in both samples are surface exposed, while those modified only in the denatured complexes are buried within the complex. The limiting amount of material and high complexity of their samples will require mass spectrometric instrumentation with very high resolution and very high sensitivity.
Public Health Relevance Statement
Data not available.
NIH Spending Category
BiotechnologyGenetics
Project Terms
BindingComplexComputer Retrieval of Information on Scientific Projects DatabaseConditionFundingGenesGrantHela CellsHeterogeneous Nuclear RNAHumanIn VitroInstitutionIntronsIsotopesMass Spectrum AnalysisNuclear ExtractPeptidesProtein BindingProteinsProtocols documentationRNA SplicingResearchResearch PersonnelResolutionResourcesSamplingSeriesSourceSpliceosomesStructureSurfaceTranscriptUnited States National Institutes of HealthinstrumentationmRNA Precursorresearch study
No Sub Projects information available for 5P41RR001614-26 6426
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P41RR001614-26 6426
Patents
No Patents information available for 5P41RR001614-26 6426
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P41RR001614-26 6426
Clinical Studies
No Clinical Studies information available for 5P41RR001614-26 6426
News and More
Related News Releases
No news release information available for 5P41RR001614-26 6426
History
No Historical information available for 5P41RR001614-26 6426
Similar Projects
No Similar Projects information available for 5P41RR001614-26 6426